Please meet us at the medical conferences Idorsia Medical Affairs is attending to learn more about our latest updates on insomnia and its management options.
American Association of Geriatric Psychiatry (AAGP) 2023 Annual Meeting
March 3-6, 2023 | New Orleans, LA | Booth Number: 300
Academy of Managed Care Pharmacy (AMCP) 2023 Annual Meeting
March 22-24, 2023 | San Antonio, TX | Booth Number: 1816
American College of Physicians (ACP) Internal Medicine Meeting 2023
April 27-29, 2023 | San Diego, CA | Booth Number: 1223
American Geriatric Society (AGS) 2023 Annual Scientific Meeting
May 4-6, 2023 | Long Beach, CA | Booth Number: 316
SLEEP 2023 Annual Meeting
June 3-7, 2023 | Indianapolis, IN | Booth Number: 800 Posters:
Impact of comorbid insomnia and nocturia on subjects’ lives as assessed through a concept elicitation study
Assessing the content validity of the IDSIQ through cognitive interviews in individuals with comorbid insomnia and nocturia
Daridorexant in patients with insomnia disorder: number needed to treat, number needed to harm & likelihood to be helped or harmed
Association between the real-world use of GABA receptor agonists and daytime impairment in US patients with insomnia
Association between the real-world use of trazodone and daytime impairment in US patients with insomnia
American Association of Nurse Practitioners (AANP) 2023 National Conference
June 20-25, 2023 | New Orleans, LA | Booth Number: 1219 Posters:
Efficacy of long-term treatment with daridorexant in patients with insomnia: a post-hoc analysis.
Association between GABA receptor agonist use and daytime impairment in US patients with insomnia.
Association between real-world use of trazodone and daytime impairment in US patients with insomnia.
American Academy of Family Practitioners (AAFP) FMX 2023 Annual Meeting
October 26-29, 2023 | Chicago, IL | Booth Number: TBD
US Consumer (e.g., patient)US Healthcare Professional
